SREBF2 and hepatocellular carcinoma: Both the EdU and CCK8 cell proliferation assays demonstrated that the proliferation of hepatocellular carcinoma cells with overexpressed HBx significantly decreased after SREBP2 was knocked down, suggesting that HBx may promote cell proliferation through SREBP2 (Figure 4F).